Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Case Report

Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensive review

Tae Suk Kim, Ji Hoon Kim, Baek hui Kim, Young-Sun Lee, Yang Jae Yoo, Seong Hee Kang, Sang-June Suh, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun

Clin Mol Hepatol. 2017;23(4):340-346. Published online June 20, 2017

DOI: https://doi.org/10.3350/cmh.2016.0070

View: 16261 Download: 198 Web of Science: 18 Crossref: 18

Original Article

Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B

Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, Byung-Ho Kim, Young Suk Lim, Seung Woon Paik, Jeong Heo, Heon-Ju Lee, Dong Joon Kim, Tae Hun Kim, Young-Sok Lee, Kwan Soo Byun, Daeghon Kim, Myung Seok Lee, Kyungha Yu, Dong Jin Suh

Clin Mol Hepatol. 2017;23(4):331-339. Published online September 26, 2017

DOI: https://doi.org/10.3350/cmh.2016.0040

View: 8298 Download: 218 Web of Science: 14 Crossref: 10

Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function

Hyun Phil Shin, Ji-Ae Park, Blaire Burman, Richard A. Kozarek, Asma Siddique

Clin Mol Hepatol. 2017;23(4):316-322. Published online August 22, 2017

DOI: https://doi.org/10.3350/cmh.2016.0087

View: 7460 Download: 190 Web of Science: 12 Crossref: 16

Editorial

Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?

Joon Yeul Nam, Jeong-Hoon Lee

Clin Mol Hepatol. 2017;23(4):311-313. Published online December 4, 2017

DOI: https://doi.org/10.3350/cmh.2017.0069

View: 6171 Download: 142

Use of sofosbuvir in chronic kidney disease: Is it necessary?

Tae Seop Lim, Sang Hoon Ahn

Clin Mol Hepatol. 2017;23(4):308-310. Published online September 26, 2017

DOI: https://doi.org/10.3350/cmh.2017.0109

View: 5946 Download: 118 Web of Science: 4 Crossref: 6

Original Article

Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir

Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin

Clin Mol Hepatol. 2017;23(3):230-238. Published online June 30, 2017

DOI: https://doi.org/10.3350/cmh.2017.0003

View: 9635 Download: 165 Web of Science: 12 Crossref: 14

Editorial

Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?

Yun Bin Lee, Jeong-Hoon Lee

Clin Mol Hepatol. 2017;23(3):219-221. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0045

View: 7813 Download: 154 Web of Science: 1 Crossref: 2

Review

Current status of and strategies for hepatitis C control in South Korea

Beom Kyung Kim, Eun Sun Jang, Jeong Han Kim, Soo Young Park, Song Vogue Ahn, Hyung Joon Kim, Do Young Kim

Clin Mol Hepatol. 2017;23(3):212-218. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0105

View: 8247 Download: 233 Web of Science: 17 Crossref: 19

Current status and strategies for hepatitis B control in Korea

Eun Ju Cho, Sung Eun Kim, Ki Tae Suk, Jihyun An, Soung Won Jeong, Woo Jin Chung, Yoon Jun Kim

Clin Mol Hepatol. 2017;23(3):205-211. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0104

View: 12931 Download: 305 Web of Science: 84 Crossref: 84

Current status and strategies for the control of viral hepatitis A in Korea

Eileen L. Yoon, Dong Hyun Sinn, Hyun Woong Lee, Ji Hoon Kim

Clin Mol Hepatol. 2017;23(3):196-204. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0034

View: 9223 Download: 207 Web of Science: 19 Crossref: 20

Current status and strategies for viral hepatitis control in Korea

Dong Hyun Sinn, Eun Ju Cho, Ji Hoon Kim, Do Young Kim, Yoon Jun Kim, Moon Seok Choi

Clin Mol Hepatol. 2017;23(3):189-195. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0033

View: 8813 Download: 244 Web of Science: 20 Crossref: 20

Case Report

Development of autoimmune hepatitis in a psoriasis patient without immunosuppressive therapy

Wonyong Jo, Young-Sun Suh, Sang-Il Lee, Yun-Hong Cheon, Jeongmin Hong, Sang Su Lee, Ji Eun Kim, Gyung Hyuck Ko, Hyun-Ok Kim

Clin Mol Hepatol. 2017;23(2):184-187. Published online May 8, 2017

DOI: https://doi.org/10.3350/cmh.2016.0035

View: 7472 Download: 115 Web of Science: 3 Crossref: 1

Original Article

Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B

Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik

Clin Mol Hepatol. 2017;23(2):170-178. Published online May 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0086

View: 9700 Download: 224 Web of Science: 52 Crossref: 45

Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B

Hee Yeon Seo, Han Ah Lee, Soon Young Ko, Joon Ho Wang, Jeong Han Kim, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2017;23(2):154-159. Published online May 8, 2017

DOI: https://doi.org/10.3350/cmh.2016.0067

View: 7548 Download: 174 Web of Science: 8 Crossref: 8

Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis

Oidov Baatarkhuu, Hye Won Lee, Jacob George, Dashchirev Munkh-Orshikh, Baasankhuu Enkhtuvshin, Sosorbaram Ariunaa, Mohammed Eslam, Sang Hoon Ahn, Kwang-Hyub Han, Do Young Kim

Clin Mol Hepatol. 2017;23(2):147-153. Published online May 2, 2017

DOI: https://doi.org/10.3350/cmh.2016.0055

View: 9400 Download: 171 Web of Science: 6 Crossref: 7

Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma

Mingkuan Su, Jianfeng Guo, Jiancheng Huang

Clin Mol Hepatol. 2017;23(2):138-146. Published online April 21, 2017

DOI: https://doi.org/10.3350/cmh.2016.0083

View: 9172 Download: 112 Web of Science: 4 Crossref: 3

Editorial

Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign?

Nae-Yun Heo

Clin Mol Hepatol. 2017;23(2):125-127. Published online June 23, 2017

DOI: https://doi.org/10.3350/cmh.2017.0106

View: 7257 Download: 141 Web of Science: 3 Crossref: 3

Review

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs

Stephen Caldwell

Clin Mol Hepatol. 2017;23(2):103-108. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0103

View: 12473 Download: 476 Web of Science: 32 Crossref: 32

Original Article

Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study

Kwang Il Seo, Byung Chul Yun, Weiquan James Li, Sang Uk Lee, Byung Hoon Han, Eun Taek Park

Clin Mol Hepatol. 2017;23(1):74-79. Published online March 3, 2017

DOI: https://doi.org/10.3350/cmh.2016.0052

View: 7675 Download: 147 Web of Science: 2 Crossref: 2

Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients

Goh Eun Chung, Eun Ju Cho, Jeong-Hoon Lee, Jeong-ju Yoo, Minjong Lee, Yuri Cho, Dong Hyeon Lee, Hwi Young Kim, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Fabien Zoulim

Clin Mol Hepatol. 2017;23(1):66-73. Published online February 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0060

View: 10111 Download: 167 Web of Science: 12 Crossref: 11

Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study

Byeong Wook Cho, Seok Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae

Clin Mol Hepatol. 2017;23(1):51-56. Published online March 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0053

View: 8051 Download: 212 Web of Science: 12 Crossref: 14

Review

The use of immunosuppression in autoimmune hepatitis: A current literature review

Angela Cropley, Martin Weltman

Clin Mol Hepatol. 2017;23(1):22-26. Published online March 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0089

View: 29420 Download: 419 Web of Science: 15 Crossref: 18

Original Article

Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization

Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi

Clin Mol Hepatol. 2016;22(4):458-465. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0054

View: 9011 Download: 134 Web of Science: 10 Crossref: 10

Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)

Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn

Clin Mol Hepatol. 2016;22(4):443-449. Published online November 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0037

View: 9971 Download: 158 Web of Science: 10 Crossref: 8

Editorial

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?

Byung-Cheol Song

Clin Mol Hepatol. 2016;22(4):439-442. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0108

View: 7665 Download: 111 Web of Science: 1 Crossref: 1

Review

Management of direct antiviral agent failures

María Buti, Rafael Esteban

Clin Mol Hepatol. 2016;22(4):432-438. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0107

View: 11284 Download: 364 Web of Science: 29 Crossref: 27

New perspectives of biomarkers for the management of chronic hepatitis B

Chih-Lin Lin, Jia-Horng Kao

Clin Mol Hepatol. 2016;22(4):423-431. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0069

View: 13107 Download: 546 Web of Science: 49 Crossref: 48

Case Report

A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy

Sung Bok Ji, Sang Soo Lee, Hee cheul Jung, Hong Jun Kim, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok Jae Lee, Dae Hyun Song

Clin Mol Hepatol. 2016;22(3):396-399. Published online August 30, 2016

DOI: https://doi.org/10.3350/cmh.2015.0039

View: 17221 Download: 117 Web of Science: 6 Crossref: 8

Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy

Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song

Clin Mol Hepatol. 2016;22(3):390-395. Published online August 30, 2016

DOI: https://doi.org/10.3350/cmh.2015.0050

View: 10765 Download: 132 Web of Science: 1 Crossref: 2

Original Article

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B

Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um

Clin Mol Hepatol. 2016;22(3):382-389. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0047

View: 12269 Download: 201 Web of Science: 18 Crossref: 19

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5413	MAFLD: How is it different from NAFLD?
Viewed By 5222	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5101	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4732	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search